Acorda Therapeutics (NSDQ:ACOR) said this week that the FDA approved its Inbrija device for the intermittent treatment of “off” episodes in people with Parkinson’s disease. The self-administered, inhaled therapy is designed for people experiencing a re-emergence of Parkinson’s symptoms. These “off” episodes are caused by low levels of dopamine between doses of the standard oral Parkinson’s […]
Neurological
Welcome to MassDevice's Neurological Hub, your resource for the latest news in the neurological device space. Stay informed about the innovations and business news shaping the neurological industry.
🧠 Narrow your focus with these categories:
Neuromodulation/Neurostimulation | Bioelectronic Medicine | Pain Management | Brain-Computer Interfaces
Here are the top neurological device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ 7 brain-computer interface companies you need to know
+ Brain breakthroughs: Aprinoia Therapeutics’ harnesses AI and strategic partnerships to propel neurodegenerative disease research
+ Natalizumab and PML: The complex dance of benefit and risk for MS
Latest Neurological News
IBM’s AI-aided fingernail sensor could help with cardio, Parkinson’s treatment
IBM has developed a fingernail sensor that it says may help healthcare providers fine-tune treatment for certain cardiovascular and neurological conditions such as Parkinson’s disease. The wearable, wireless device measures how a person’s fingernail bends and moves throughout the day – a key indicator of grip strength. The prototype sensor continually collects data and feeds […]
ForeSee Medical raises $6m
Cognitive healthcare software developer ForeSee Medical has raised $6 million in a new round of equity financing, according to a recently posted SEC filing. Money in the round came from 12 anonymous investors, with the first sale noted on September 11, according to the filing. The San Diego-based company is developing cognitive software intended to improve […]
How an ‘imaging needle’ can help prevent brain bleeds
A team of researchers and clinicians led by the University of Adelaide in South Australia has found that an “imaging needle” may reduce the risk of dangerous brain bleeds in patients undergoing brain biopsy. Published today in the journal Science Advances, the study describes how they fashioned the imaging device with a tiny fiber-optic camera encased […]
Nerve repair dev Neuraptive Therapeutics raises $12m in Series A
Neuraptive Therapeutics said yesterday that it raised $11.5 million in a Series A round of equity financing to support its flagship AxoFuse nerve repair system through clinical trials and to expand operations. The round was led by private equity firm New Rhein Healthcare Investors, the Lafayette, Colo.-based company said. The AxoFuse system is a novel […]
FDA expands indication for Insightec’s Exablate Neuro in Parkinson’s
Insightec said this week that the FDA approved an expansion for the Exablate Neuro device to include the treatment of patients with tremor-dominant Parkinson’s disease. The company’s device uses focused ultrasound to perform an incision-less thalamotomy, guided by MR imaging. The Exablate Neuro was previously only approved for medication-refractory essential tremor. “This is another validation […]
Renerva lands $2.4 million to develop ‘Neosporin of nerve repair’
Nerve-repair startup Renerva said today it has received $2.4 million in funding from the U.S. Department of Defense. The Pittsburgh company is developing a periheral nerve matrix (PNM), an injectable gel derived from porcine tissue to help repair and regenerate injured peripheral nerves. The Medical Technology Enterprise Consortium (MTEC) Award award will enable Renerva to complete its preclinical […]
J&J’s Cerenovus launches global thrombectomy registry
Johnson & Johnson‘s (NYSE:JNJ) Cerenovus said today that it launched a new registry aiming to collect and analyze stroke-inducing blood clots removed with the company’s Embotrap II revascularization device. The Irvine, Calif.-based company touted the Excellent registry as the single largest global registry of its kind to date, looking to enroll up to 1,000 ischemic stroke patients […]
Early stage neural device dev Tulavi Therapeutics raises $3m
Early stage medical device developer Tulavi Therapeutics has raised approximately $3 million in a new round of equity financing, according to recently posted SEC filings. Tulavi Therapeutics is developing a medical device-based therapy intended to prevent or treat aberrant neural reflex arcs in peripheral and visceral disease. The technology is intended for use through both […]
Neural Analytics adds $10m for robot-assisted brain ultrasound
Neural Analytics yesterday reported raising nearly $10 million for the robot-assisted brain ultrasound device it’s developing. Los Angeles-based Neural Analytics’ NeuralBot is designed to work with its Lucid M1 transcranial doppler utrasound to provide non-invasive blood flow monitoring. In June the company won CE Mark approval in the European Union for NeuralBot. In a funding round begun […]
ElectroCore wins cluster headache FDA 510(k) indication for GammaCore
ElectroCore said today that it won expanded FDA 510(k) clearance for its GammaCore non-invasive vagus nerve stimulation therapy, now cleared for adjunctive use for the preventive treatment of cluster headaches in adult patients. The Basking Ridge, N.J.-based company’s GammaCore device is a non-invasive, hand-held vagus nerve stimulation device designed for the reduction of pain. The system […]